| For: | Fonseca GM, Varella AD, Coelho FF, Abe ES, Dumarco RB, Herman P. Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma. World J Gastrointest Surg 2014; 6(6): 107-111 [PMID: 24976904 DOI: 10.4240/wjgs.v6.i6.107] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v6/i6/107.htm |
| Number | Citing Articles |
| 1 |
E. Yu. Antonova, E. A. Moroz, I. A. Dzhanyan, A. Yu. Volkov, K. K. Laktionov, V. V. Breder. Optimal choice of drug antitumor treatment in patients with Fibrolamellar liver carcinoma. Meditsinskiy sovet = Medical Council 2022; (22) doi: 10.21518/2079-701X-2022-16-22-130-135
|
| 2 |
Sebastian Mafeld, Jeremy French, Dina Tiniakos, Beate Haugk, Derek Manas, Peter Littler. Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection. CardioVascular and Interventional Radiology 2018; 41(5) doi: 10.1007/s00270-018-1903-6
|
| 3 |
Ju Dong Yang, Lewis R. Roberts. Zakim and Boyer's Hepatology. 2018; doi: 10.1016/B978-0-323-37591-7.00048-3
|
| 4 |
Mark Rassner, Beate Häberle, Rebecca Maxwell, Julia von Frowein, Roland Kappler, Michael Rassner, Christian Vokuhl, Dietrich von Schweinitz, Irene Schmid. Does Chemotherapy Have an Effect on the Treatment Success of Children and Adolescents with Unresectable Hepatocellular Carcinoma? Findings from the German Liver Tumour Registry. Cancers 2025; 17(15) doi: 10.3390/cancers17152444
|
| 5 |
Miral Sadaria Grandhi, Timothy M. Pawlik. Managing fibrolamellar hepatocellular carcinoma. Expert Opinion on Orphan Drugs 2017; 5(2) doi: 10.1080/21678707.2017.1268050
|
| 6 |
E. Yu. Antonova, V. V. Breder, E. A. Moroz, K. K. Laktionov, I. A. Dzhanyan, A. Yu. Volkov. Fibrolamellar liver cancer: the modern concept. Meditsinskiy sovet = Medical Council 2020; (20) doi: 10.21518/2079-701X-2020-20-134-142
|
| 7 |
Hiroki Tanaka, Susumu Hijioka, Hiromichi Iwaya, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Ayako Ito, Naosuke Kuraoka, Shinpei Matsumoto, Masahiro Obata, Yusuke Kurita, Muneji Yasuda, Yasuhiro Shimizu, Hiroaki Kuroda, Yozo Sato, Masataka Haneda, Eiichi Sasaki, Yasushi Yatabe, Kazuo Hara. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy. Internal Medicine 2018; 57(24) doi: 10.2169/internalmedicine.1243-18
|
| 8 |
Allison F. O’Neill, Emily L. Zeme, Ghassan K. Abou-Alfa, Marina Baretti, Alexander J. Bondoc, Alanna Church, Cristina R. Ferrone, Megan Fitzgerald, James I. Geller, Anne E. Gill, William P. Harris, Heung Bae Kim, Sunyoung S. Lee, Kevin X. Liu, Michael V. Ortiz, Arun Rangaswami, Kimberly J. Riehle, Abby R. Rosenberg, Michael S. Torbenson, Mark Yarchoan, John D. Gordan. Clinical guideline for the diagnosis and treatment of fibrolamellar carcinoma. Hepatology 2026; 84(4) doi: 10.1097/HEP.0000000000001700
|
| 9 |
F. Lo Prinzi, S. Camera, S. Foti, M. Persano, C.M. Gullotta, F. Rossari, F. Vitiello, L. Passeri, F. Michele, A. Casadei-Gardini, M. Rimini. Clinical characteristics and outcome of patients with fibrolamellar hepatocellular carcinoma: an analysis of a large population using real-world data. ESMO Gastrointestinal Oncology 2025; 10 doi: 10.1016/j.esmogo.2025.100272
|
| 10 |
Sara Gottlieb, Claire O’Grady, Ariel Gliksberg, Paul Kent. Early Experiences with Triple Immunochemotherapy in Adolescents and Young Adults with High-Risk Fibrolamellar Carcinoma. Oncology 2021; 99(5) doi: 10.1159/000513358
|
| 11 |
Hideyuki Wada, Hoon Hyun, Christina Vargas, Elizabeth M. Genega, Julien Gravier, Sylvain Gioux, John V. Frangioni, Hak Soo Choi. Sentinel Lymph Node Mapping of Liver. Annals of Surgical Oncology 2015; 22(S3) doi: 10.1245/s10434-015-4601-5
|
| 12 |
Irene Schmid, Allison F. O’Neill, Kenichiro Watanabe, Isabelle Aerts, Sophie Branchereau, Penelope R. Brock, Madhumita Dandapani, Brice Fresneau, Jim Geller, Tomoro Hishiki, Danielle Ingham, Kathelijne Kraal, Milind Ronghe, Greg Tiao, Angela Trobaugh-Lotrario, Arun Rangaswami, Michael J. Sullivan, Jozsef Zsiros, Eiso Hiyama, Marcio Malogolowkin, Marc Ansari. Global consensus from the PHITT consortium surrounding an interim chemotherapy guidance for the treatment of children with hepatoblastoma, hepatocellular neoplasm – not otherwise specified (HCN-NOS), hepatocellular carcinoma and fibrolamellar carcinoma after trial closure. EJC Paediatric Oncology 2025; 5 doi: 10.1016/j.ejcped.2025.100235
|
| 13 |
Leonardo G Da Fonseca, Victor Junji Yamamoto, Mateus Trinconi Cunha, Giovanna Sawaya Torre, Raphael Araujo, Gilton Marques Fonseca, Andre Tsin Chih Chen, Aline Chagas, Paulo Herman, Venancio Avancini Ferreira Alves, Flair Jose Carrilho. Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S428741
|
| 14 |
Jairo A. Espinosa, Alex Merlo, Mohamed-Omar Arafeh, Gitonga Munene. An unusual case of jaundice: Biliary tumor thrombus in fibrolamellar hepatocellular carcinoma. International Journal of Surgery Case Reports 2017; 36 doi: 10.1016/j.ijscr.2017.03.039
|
| 15 |
Benjamin A. Farber, Gadi Lalazar, Elana P. Simon, William J. Hammond, David Requena, Umesh K. Bhanot, Michael P. La Quaglia, Sanford M. Simon. Non coding RNA analysis in fibrolamellar hepatocellular carcinoma. Oncotarget 2018; 9(12) doi: 10.18632/oncotarget.23325
|
| 16 |
Georgios Polychronidis, Anastasia Murtha-Lemekhova, Juri Fuchs, Evdokia Karathanasi, Katrin Hoffmann. A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects. OncoTargets and Therapy 2022; doi: 10.2147/OTT.S296127
|
| 17 |
Hassan Aziz, Zachary J Brown, Seyedeh Panid Madani, Ihab R Kamel, Timothy M Pawlik. Fibrolamellar Hepatocellular Carcinoma: Comprehensive Review of Diagnosis, Imaging, and Management. Journal of the American College of Surgeons 2023; 236(2) doi: 10.1097/XCS.0000000000000476
|
| 18 |
Dolores López-Terrada, Rita Alaggio. Pathology of Pediatric Gastrointestinal and Liver Disease. 2024; doi: 10.1007/978-3-031-62589-3_14
|
| 19 |
Antonio Costantino, Tamar H. Taddei. Primary Liver Tumors Other than Hepatocellular Carcinoma: Clinical and Molecular Pearls. Current Hepatology Reports 2018; 17(4) doi: 10.1007/s11901-018-0426-6
|
| 20 |
Yasir Alshareefy, Chai Yu Shen, Rosheene Jeya Prekash. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature. Pathology - Research and Practice 2023; 248 doi: 10.1016/j.prp.2023.154655
|
| 21 |
Allison F. O'Neill, Alanna J. Church, Antonio R. Perez-Atayde, Raja Shaikh, Karen J. Marcus, Khashayar Vakili. Fibrolamellar carcinoma: An entity all its own. Current Problems in Cancer 2021; 45(4) doi: 10.1016/j.currproblcancer.2021.100770
|
| 22 |
Laura Depauw, Glenn De Weerdt, Ben Gys, Sofie Demeulenaere, Wouter Mebis, Dirk Ysebaert. Pediatric fibrolamellar hepatocellular carcinoma: case report and review of the literature. Acta Chirurgica Belgica 2021; 121(3) doi: 10.1080/00015458.2019.1660060
|
| 23 |
Sandra Kang, Joseph Magliocca, Marty Sellers, Giorgio Roccaro, Wei Zheng, Melina Pectasides, Amber Draper, Jessica Guadagno, Bassel El-Rayes, Mehmet Akce. Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report. Oncology Research and Treatment 2022; 45(7-8) doi: 10.1159/000524872
|
| 24 |
Imane El Dika, Robert J. Mayer, Alan P. Venook, Marinela Capanu, Michael P. LaQuaglia, Rachel Kobos, Allison F. O'Neill, Joanne F. Chou, Michele Ly, Celina Ang, Eileen M. O'Reilly, John D. Gordan, Ghassan K. Abou-Alfa. A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma. The Oncologist 2020; 25(11) doi: 10.1634/theoncologist.2020-0367
|
| 25 |
Oscar Suarez, María Perez, Martin Garzon, Rodrigo Daza, Geovanny Hernandez, Carolina Salinas, Jorge Ceballos, Enrique P. de Leon, Jacqueline Mugnier, Oscar Beltrán, Adriana Varón. Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy. Case Reports in Hepatology 2018; 2018 doi: 10.1155/2018/7521986
|
| 26 |
William J. Hammond, Gadi Lalazar, James A. Saltsman, Benjamin A. Farber, Enrico Danzer, Tshering C. Sherpa, Charles D. Banda, Jeffrey R. Andolina, Sasan Karimi, Cameron W. Brennan, Michael S. Torbenson, Michael P. La Quaglia, Sanford M. Simon. Intracranial metastasis in fibrolamellar hepatocellular carcinoma. Pediatric Blood & Cancer 2018; 65(4) doi: 10.1002/pbc.26919
|